@WatmighthavbenYou certainly don't seem comfortable to me.
Let's compare our notes
Mason14 (21/05/21):
40.5c Sell (speaking about Her-Vaxx reporting of data) "However, had a 95% confidence interval been used, the result would not have been significant, as the upper bound would have crossed one. The standard for FDA approval is 95% confidence intervals, which, if used in this study, would indicate that the results seen in these interim results are not significant. By comparison, the study of herceptin that the announcement elluded to had a HR of 0.74 with a 95% CI of 0.61–0.91, indicating that herceptin + chemo has a 95% chance of showing benefit (4)."
https://hotcopper.com.au/threads/why-imu-is-a-multi-multi-bagger.5431324/page-1629?post_id=53343379Ben (25/05/21):
40.5c Buy "Once again the trial results speak for themselves. And if the pre clinical data derived from CF 33 and CD 19 plays out in their ensuing Phase 1 and 2 trials, Imugene shall soon rival some of their larger competitors as their proof of concept comes to fruition in a safe, efficacious and timely manner. I know I’ll definitely be staying on the train to enjoy the ride."
https://hotcopper.com.au/threads/why-imu-is-a-multi-multi-bagger.5431324/page-1762?post_id=53355688--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Mason (28/09/21):
48c Sell "I have looked at the results in depth and shared my research publicly. I have extensively compared the findings of HER-Vaxx phase 2b trial to industry standards and the Herceptin TOGA study, and found major holes that no one is addressing. Maybe it is you that needs to look at the results. HER-Vaxx failed to show a significant benefit over standard of care chemotherapy for PFS in this patient population.I encourage anyone on this forum to take the time to prove where that has not happened."
https://hotcopper.com.au/threads/why-imu-is-a-multi-multi-bagger.5431324/page-3868?post_id=56411308Ben (21/11/21):
56.5c Buy "For when the US investment kicks in, bringing with it millionaires, perhaps billionaires, and the savvy biotech investors spoken of earlier in this post, IMU(ASX) stock is going to look and taste a lot more like confiture, than confetti. When large hedge funds such as Baker Brothers in the US dust off and activate that file that has been sitting in their bottom drawer “awaiting data”, watch out. IMU shares are going to be as scarce as an invite to their forthcoming Christmas party. After all, “Who wants to kill the goose that’s about to lay the golden egg?” ....
"Don’t miss out on the opportunity of a lifetime to join her on the journey. It may well be less than 15 years in the making"https://hotcopper.com.au/threads/why-imu-is-a-multi-multi-bagger.5431324/page-4588?post_id=57729664--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
And now you think you will get away with saying that the clinical programs are embryonic? What happened to the opportunity of a lifetime?
(20min delay)